Comparison of the infectivity of trypanosoma cruzi insect-derived metacyclic trypomastigotes after mucosal and cutaneous contaminative challenges

Memorias do Instituto Oswaldo Cruz

Volumn 108, Issue 4, 2013, Pages 508-511

  Eickhoff, Christopher Steven ^a   Dunn, Brian Anthony ^a   Sullivan, Nicole Lea ^a   Hoft, Daniel Fredric ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal disease models; Chagas disease; Infection control; Mucosal immunity; Trypanosoma cruzi

Indexed keywords

ANIMALIA; HEXAPODA; MUS; TRYPANOSOMA CRUZI;

EID: 84878769385     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762013000400018     Document Type: Article

References (17)

1. Benchimol Barbosa PR 2006. The oral transmission of Chagas disease: an acute form of infection responsible for regional outbreaks. Int J Cardiol 112: 132-133.
2. Camargo EP 1964. Growth and differentiation in Trypanosoma cruzi: I. Origin of metacyclic trypanosomes in liquid media. Rev Inst Med Trop Sao Paulo 6: 93-100.
3. CDC - Centers for Disease Control 2007. Blood donor screening for Chagas disease - United States, 2006-2007. MMWR Morb Mortal Wkly Rep 56: 141-143.
4. Cortez C, Martins RM, Alves RM, Silva RC, Bilches LC, Macedo S, Atayde VD, Kawashita SY, Briones MR, Yoshida N 2012. Differential infectivity by the oral route of Trypanosoma cruzi lineages derived from y strain. PLoS Negl Trop Dis 6: e1804.
5. Díaz-Ungria C 1968. Estudio experimental del Trypanosoma cruzi en el perro y otros vertebrados. El problema de la transmisión. Kasmera 3: 73-88.
6. Eickhoff CS, Vasconcelos JR, Sullivan NL, Blazevic A, Bruna-Romero O, Rodrigues MM, Hoft DF 2011. Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi. PLoS Negl Trop Dis 5: e983.
7. Giddings OK, Eickhoff CS, Smith TJ, Bryant LA, Hoft DF 2006. Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection. Infect Immun 74: 5549-5560.
8. Gus I, Molon ME, Bueno AP 1993. Chagas disease-review of 8 simultaneous cases of acute Chagas myocarditis: 25 years later. Arq Bras Cardiol 60: 99-101.
9. Hoft DF, Eickhoff CS 2005. Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen. Infect Immun 73: 4934-4940.
10. Hoft DF, Farrar PL, Kratz-Owens K, Shaffer D 1996. Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses. Infect Immun 64: 3800-3810.
11. Kirchhoff LV, Hieny S, Shiver M, Snary D, Sher A 1984. Cryptic epitope explains the failure of a monoclonal antibody to bind to certain isolates of Trypanosoma cruzi. J Immunol 133: 2731-2735.
12. Kirchhoff LV, Hoft DF 1990. Immunization and challenge of mice with insect-derived metacyclic trypomastigotes of Trypanosoma cruzi. Parasite Immunol 12: 65-74.
13. Schnapp AR, Eickhoff CS, Sizemore D, Curtiss III R, Hoft DF 2002. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect Immun 70: 5065-5074.
14. Shaw J, Lainson R, Fraiha H 1969. Considerações sobre a epidemiologia dos primeiros casos autóctones de doença de Chagas registrados em Belém, Pará, Brasil. Rev Saude Publica 3: 153-157.
15. Steindel M, Kramer PL, Scholl D, Soares M, de Moraes MH, Eger I, Kosmann C, Sincero TC, Stoco PH, Murta SM, Carvalho-Pinto CJ, Grisard EC 2008. Characterization of Trypanosoma cruzi isolated from humans, vectors and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina state, Brazil. Diagn Microbiol Infect Dis 60: 25-32.
16. Titus RG, Ribeiro JM 1988. Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science 239: 1306-1308.
17. WHO - World Health Organization 2010. Chagas disease (American trypanosomiasis). Available from: who.int/neglected_diseases/diseases/chagas/en/.